Yuvraj

CSL Behring begins pediatric Phase III hemophilia B study of rIX-FP

CSL Behring has commenced the patient enrollment in pivotal pediatric Phase III hemophilia B study of recombinant fusion protein linking coagulation factor IX...

PCT to provide development, manufacturing services to Adaptimmune

Progenitor Cell Therapy (PCT), a subsidiary of NeoStem, has signed an agreement to provide cell product development and manufacturing services for Adaptimmune's clinical...

Almac Successfully Completes Knowledge Transfer Partnership with Queens University with Highest Accolade

Almac is pleased to announce the successful completion of the Knowledge Transfer Partnership (KTP) with Queens University Belfast, to develop, improve and embed...

Potential new treatment for gastrointestinal cancers discovered

Researchers have identified a complex of proteins that promotes the growth of some types of colon and gastric cancers, and shown that medications...

GlycoMimetics completes enrollment in Phase 2 study of GMI-1070

Clinical-stage biotechnology company GlycoMimetics has completed patient enrollment for the Phase 2 sickle cell disease study evaluating GMI-1070. Hospitalized...

Mevesi announces new partnership with Mobile MedSoft

Business intelligence service provider Mevesi has signed a new collaboration agreement with Mobile MedSoft. Under the collaboration, Mobile MedSoft's...

Amgen to invest $200m in new Singapore manufacturing facility

Amgen is planning to invest $200m to construct a manufacturing facility in the Tuas Biomedical Park area of Singapore. ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read